Uğur Çevikbaş
Impact in
- Hepatology top 5%
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Surgery 23
- Diagnosis and treatment of tuberculosis 4
- Pediatric Hepatobiliary Diseases and Treatments 4
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 9
- Hepatitis B Virus Studies 5
- Co-authors
- Müjdat Uysal (11 shared papers)Jale Balkan (11 shared papers)Necla Koçak‐Toker (5 shared papers)Gülçin Aykaç‐Toker (7 shared papers)Güldal Mehmetçik (2 shared papers)Gül Özdemirler (2 shared papers)Öznur Kanbağlı (3 shared papers)Mutlu Küçük (3 shared papers)
- Journals
- Surgery Today (4 papers)Journal of Hepatology (4 papers)Human & Experimental Toxicology (4 papers)Bioscience Biotechnology and Biochemistry (3 papers)Experimental and Toxicologic Pathology (3 papers)
- Partner nations
- TürkiyeUnited StatesCyprus
In The Last Decade
Uğur Çevikbaş
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Hepatology 161
- Pharmacology 105
- Cell Biology 191
- Epidemiology 259
- Nutrition and Dietetics 124
Countries citing papers authored by Uğur Çevikbaş
This map shows the geographic impact of Uğur Çevikbaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uğur Çevikbaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uğur Çevikbaş more than expected).
Fields of papers citing papers by Uğur Çevikbaş
This network shows the impact of papers produced by Uğur Çevikbaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uğur Çevikbaş. The network helps show where Uğur Çevikbaş may publish in the future.
Co-authors
The 25 scholars most cited alongside Uğur Çevikbaş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 105 | |
| 2 | 2001 | 99 | |
| 3 | 2008 | 92 | |
| 4 | 1994 | 88 | |
| 5 | 2002 | 83 | |
| 6 | 2002 | 79 | |
| 7 | 2004 | 76 | |
| 8 | 2001 | 74 | |
| 9 | 2004 | 56 | |
| 10 | 1998 | 47 | |
| 11 | 2007 | 46 | |
| 12 | 2007 | 41 | |
| 13 | 2004 | 36 | |
| 14 | 2010 | 34 | |
| 15 | 1998 | 31 | |
| 16 | Tuberculosis of the parotid gland. | 1998 | 30 |
| 17 | Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? | 2011 | 29 |
| 18 | 1983 | 21 | |
| 19 | 2004 | 20 | |
| 20 | 2010 | 18 |
About Uğur Çevikbaş
Uğur Çevikbaş is a scholar working on Surgery, Epidemiology, Hepatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Biochemical effects in animals (6 papers), Hepatitis B Virus Studies (5 papers), Aldose Reductase and Taurine (5 papers), Diagnosis and treatment of tuberculosis (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers), Hepatitis C virus research (3 papers) and Biliary and Gastrointestinal Fistulas (3 papers). The work is most often cited by research in Hepatology (161 citations), Pharmacology (105 citations), Cell Biology (191 citations), Epidemiology (259 citations) and Nutrition and Dietetics (124 citations). Uğur Çevikbaş has collaborated with scholars based in Türkiye, United States and Cyprus. Frequent co-authors include Müjdat Uysal, Jale Balkan, Necla Koçak‐Toker, Gülçin Aykaç‐Toker, Güldal Mehmetçik, Gül Özdemirler, Öznur Kanbağlı, Mutlu Küçük, Atilla Ökten and Fatih Beşışık. Their work appears in journals such as Surgery Today, Journal of Hepatology, Human & Experimental Toxicology, Bioscience Biotechnology and Biochemistry and Experimental and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.